Beate Sander
Beate Sander
University Health Network
Verified email at
Cited by
Cited by
Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model
B Sander, A Nizam, LP Garrison Jr, MJ Postma, ME Halloran, ...
Value in Health 12 (2), 226-233, 2009
Modelling mitigation strategies for pandemic (H1N1) 2009
MZ Gojovic, B Sander, D Fisman, MD Krahn, CT Bauch
Cmaj 181 (10), 673-680, 2009
Human pathogens associated with the blacklegged tick Ixodes scapularis: a systematic review
MP Nelder, CB Russell, NJ Sheehan, B Sander, S Moore, Y Li, S Johnson, ...
Parasites & vectors 9 (1), 1-14, 2016
A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs
B Sander, V Elliot-Gibson, DE Beaton, ER Bogoch, A Maetzel
JBJS 90 (6), 1197-1205, 2008
Long-term sequelae of West Nile virus-related illness: a systematic review
H Patel, B Sander, MP Nelder
The Lancet Infectious Diseases 15 (8), 951-959, 2015
Mega‐dose vitamin C in treatment of the common cold: a randomised controlled trial
C Audera, RV Patulny, BH Sander, RM Douglas
Medical journal of Australia 175 (7), 359-362, 2001
Mega‐dose vitamin C in treatment of the common cold: a randomised controlled trial
C Audera, RV Patulny, BH Sander, RM Douglas
Medical journal of Australia 175 (7), 359-362, 2001
Preventing pressure ulcers in long-term care: a cost-effectiveness analysis
A Stern, W Chen, B Sander, A John-Baptiste, HH Thein, T Gomes, ...
Archives of internal medicine 171 (20), 1839-1847, 2011
The economic impact of Clostridium difficile infection: a systematic review
N Nanwa, T Kendzerska, M Krahn, JC Kwong, N Daneman, W Witteman, ...
Official journal of the American College of Gastroenterology| ACG 110 (4 …, 2015
Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis
B Sander, JC Kwong, CT Bauch, A Maetzel, A McGeer, JM Raboud, ...
PLoS medicine 7 (4), e1000256, 2010
Economic burden of obesity and its complications in Germany
B Sander, R Bergemann
The European Journal of Health Economics, formerly: HEPAC 4 (4), 248-253, 2003
Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: a validation study
L Lapointe-Shaw, F Georgie, D Carlone, O Cerocchi, H Chung, Y Dewit, ...
PLoS One 13 (8), e0201120, 2018
Systematic review of the cost-effectiveness of influenza immunization programs
EEK Ting, B Sander, WJ Ungar
Vaccine 35 (15), 1828-1843, 2017
Estimation of COVID-19–induced depletion of hospital resources in Ontario, Canada
K Barrett, YA Khan, S Mac, R Ximenes, DMJ Naimark, B Sander
Cmaj 192 (24), E640-E646, 2020
The cost-effectiveness of pneumococcal conjugate vaccination in Australia
JRG Butler, P McIntyre, CR MacIntyre, R Gilmour, AL Howarth, B Sander
Vaccine 22 (9-10), 1138-1149, 2004
Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience
B Sander, CT Bauch, D Fisman, RA Fowler, JC Kwong, A Maetzel, ...
Vaccine 28 (38), 6210-6220, 2010
Cost effectiveness of hepatocellular carcinoma surveillance after a sustained virologic response to therapy in patients with hepatitis C virus infection and advanced fibrosis
HF Zangneh, WWL Wong, B Sander, CM Bell, K Mumtaz, M Kowgier, ...
Clinical Gastroenterology and Hepatology 17 (9), 1840-1849. e16, 2019
Reactive strategies for containing developing outbreaks of pandemic influenza
S Andradóttir, W Chiu, D Goldsman, ML Lee, KL Tsui, B Sander, ...
BMC public health 11 (1), 1-15, 2011
The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review
S Mac, SR da Silva, B Sander
PLoS One 14 (1), e0210280, 2019
Cost-effectiveness of palivizumab for respiratory syncytial virus: a systematic review
S Mac, A Sumner, S Duchesne-Belanger, R Stirling, M Tunis, B Sander
Pediatrics 143 (5), 2019
The system can't perform the operation now. Try again later.
Articles 1–20